JENNIFER RANKIE: Open Payments
NPI 1700808920 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,510 in 105 payments from 14 companies in 2025. Trend: 2023 $1,114 · 2024 $1,590 · 2025 $2,510
Food & beverage: $2,510
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $554 |
| GlaxoSmithKline, LLC. | 28 | $502 |
| Regeneron Healthcare Solutions, Inc. | 12 | $355 |
| AstraZeneca Pharmaceuticals LP | 15 | $343 |
| Grifols USA, LLC | 11 | $211 |
| Viatris Specialty LLC | 10 | $144 |
| Regeneron Pharmaceuticals, Inc. | 1 | $126 |
| Verona Pharma, Inc. | 3 | $71 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $67 |
| Electromed, Inc. | 2 | $42 |
Products named: DUPIXENT, NUCALA, Prolastin-C Liquid, YUPELRI, TRELEGY ELLIPTA, BREZTRI, FASENRA, AIRSUPRA.
Industry payments across NY — which companies pay providers there.
